CME Group Inc (CME) Position Lifted by Argent Trust Co

Share on StockTwits

Argent Trust Co increased its stake in CME Group Inc (NASDAQ:CME) by 280.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,375 shares of the financial services provider’s stock after buying an additional 5,435 shares during the period. Argent Trust Co’s holdings in CME Group were worth $1,387,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of CME. Sheaff Brock Investment Advisors LLC increased its position in CME Group by 0.3% during the 4th quarter. Sheaff Brock Investment Advisors LLC now owns 22,040 shares of the financial services provider’s stock valued at $4,146,000 after purchasing an additional 60 shares during the period. Dorsey & Whitney Trust CO LLC increased its position in CME Group by 1.4% during the 4th quarter. Dorsey & Whitney Trust CO LLC now owns 4,575 shares of the financial services provider’s stock valued at $860,000 after purchasing an additional 65 shares during the period. Private Trust Co. NA increased its position in CME Group by 1.9% during the 4th quarter. Private Trust Co. NA now owns 3,488 shares of the financial services provider’s stock valued at $656,000 after purchasing an additional 66 shares during the period. Ascension Asset Management LLC increased its position in CME Group by 0.6% during the 4th quarter. Ascension Asset Management LLC now owns 12,385 shares of the financial services provider’s stock valued at $2,330,000 after purchasing an additional 75 shares during the period. Finally, Rehmann Capital Advisory Group increased its position in CME Group by 5.4% during the 3rd quarter. Rehmann Capital Advisory Group now owns 1,650 shares of the financial services provider’s stock valued at $281,000 after purchasing an additional 85 shares during the period. 90.59% of the stock is currently owned by institutional investors.

A number of research analysts have commented on the stock. BidaskClub downgraded shares of CME Group from a “buy” rating to a “hold” rating in a research report on Thursday, January 31st. Keefe, Bruyette & Woods reaffirmed a “hold” rating and issued a $184.00 price objective on shares of CME Group in a research report on Monday, December 10th. Citigroup assumed coverage on shares of CME Group in a research report on Tuesday, November 20th. They issued a “buy” rating and a $220.00 price objective on the stock. Atlantic Securities assumed coverage on shares of CME Group in a research report on Wednesday, November 28th. They issued a “neutral” rating and a $200.00 price objective on the stock. Finally, Bank of America reaffirmed a “buy” rating and issued a $200.00 price objective on shares of CME Group in a research report on Monday, November 5th. Nine research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. CME Group currently has an average rating of “Hold” and an average target price of $195.21.

Shares of CME Group stock opened at $180.40 on Thursday. The company has a current ratio of 1.09, a quick ratio of 1.09 and a debt-to-equity ratio of 0.15. CME Group Inc has a 52-week low of $153.90 and a 52-week high of $197.08. The company has a market capitalization of $60.81 billion, a PE ratio of 37.82, a PEG ratio of 2.18 and a beta of 0.30.

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 25th. Stockholders of record on Friday, March 8th will be given a $0.75 dividend. The ex-dividend date of this dividend is Thursday, March 7th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.66%. This is an increase from CME Group’s previous quarterly dividend of $0.70. CME Group’s payout ratio is presently 58.70%.

In related news, CFO John W. Pietrowicz sold 17,960 shares of CME Group stock in a transaction that occurred on Wednesday, January 2nd. The shares were sold at an average price of $186.92, for a total value of $3,357,083.20. Following the completion of the sale, the chief financial officer now directly owns 44,780 shares in the company, valued at approximately $8,370,277.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Julie Winkler sold 5,847 shares of CME Group stock in a transaction that occurred on Friday, November 16th. The stock was sold at an average price of $195.01, for a total transaction of $1,140,223.47. Following the completion of the sale, the insider now owns 24,255 shares of the company’s stock, valued at $4,729,967.55. The disclosure for this sale can be found here. Insiders sold a total of 52,494 shares of company stock valued at $9,967,852 over the last quarter. 0.43% of the stock is owned by company insiders.

ILLEGAL ACTIVITY WARNING: This piece of content was first published by Week Herald and is the sole property of of Week Herald. If you are accessing this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international trademark and copyright legislation. The correct version of this piece of content can be accessed at https://weekherald.com/2019/02/14/cme-group-inc-cme-position-lifted-by-argent-trust-co.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

See Also: Cost of equity and a company’s balance sheet

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply